4
Changes in Ownership
Karyopharm Therapeutics Inc. Filed Acc 0001209191-22-014629
EVP, Chief Dev. Officer sold 1,663 shares at $10.24 ($17,025)
- EVP, Chief Dev. Officer acquired 68,250 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Frenkel Ran EVP, Chief Dev. Officer | 2022-02-28 | Grant or award | +68,250 | 169,953 | D | ||
| Frenkel Ran EVP, Chief Dev. Officer | 2022-02-28 | Sale | −1,663 | $10.24 | $17,025 | 168,290 | D |
| Derivatives | |||||||
| Frenkel Ran EVP, Chief Dev. Officer | 2022-02-28 | Grant or award · Stock Option (right to buy) | +90,000 | 90,000 | D | ||
| Open-market sales · 1,663 sh · avg $10.24 · $17,025 | |||||||
Loading xslF345X03/doc4.xml…